Mr. Justin Lumetta is a pharmacist who is specialized in Oncology in Iowa City, Iowa. Patients can reach him at 500 E Market St, Iowa City or contact him on 319-688-7256. Active license number of Mr. Justin Lumetta is 22599 for Oncology in Iowa. Mr. Justin Lumetta is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Mr. Justin Lumetta speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Mr. Justin Lumetta
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Male
Location:
500 E Market St, Iowa City, Iowa, 52245-2633
Phone:
319-688-7256
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mr. Justin Lumetta are as mentioned below.
NPI Number:
1659076602
NPI Enumeration Date:
31 Mar, 2023
NPI Last Update On:
31 Mar, 2023
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mr. Justin Lumetta are as mentioned below.
Specialization
License Number
State
Status
Oncology
22599
Iowa
Primary
Pharmacotherapy
22599
Iowa
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
500 E Market St, Iowa City, Iowa
Zip:
52245-2633
Phone Number:
319-688-7256
Fax Number:
--
Patients can reach Mr. Justin Lumetta at 500 E Market St, Iowa City, Iowa or can call on phone at 319-688-7256.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.